BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23221507)

  • 1. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
    Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
    Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
    Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
    Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species in peripheral blood and sputum neutrophils during bacterial and nonbacterial acute exacerbation of chronic obstructive pulmonary disease.
    Vaitkus M; Lavinskiene S; Barkauskiene D; Bieksiene K; Jeroch J; Sakalauskas R
    Inflammation; 2013 Dec; 36(6):1485-93. PubMed ID: 23872721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
    Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
    Yao C; Liu X; Tang Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients.
    Ruan W; Wu M; Shi L; Li F; Dong L; Qiu Y; Wu X; Ying K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1775-1780. PubMed ID: 28684903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of new laboratory tests to discriminate bacterial from nonbacterial chronic obstructive pulmonary disease exacerbations.
    van de Geijn GM; Denker S; Meuleman-van Waning V; Koeleman HG; Birnie E; Braunstahl GJ; Njo TL
    Int J Lab Hematol; 2016 Dec; 38(6):616-628. PubMed ID: 27459873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation.
    Gao D; Chen X; Wu H; Wei H; Wu J
    Exp Ther Med; 2017 Jul; 14(1):193-198. PubMed ID: 28672914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil CD64 Expression as a Diagnostic Marker in Patients Hospitalized with Exacerbations of COPD: A Prospective Observational Study.
    Titova E; Aune MW; Fonn K; Henriksen AH; Åsberg A
    Lung; 2015 Oct; 193(5):717-24. PubMed ID: 26174093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial infection, airway and systemic inflammation and clinical outcomes before and after treatment of AECOPD, a longitudinal and cross-sectional study.
    Chang C; Zhu H; Shen N; Chen Y; He B; Zhao J; Yao W
    COPD; 2015 Feb; 12(1):19-30. PubMed ID: 24800883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Qian W; Huang GZ
    Immunol Invest; 2016 Aug; 45(6):490-503. PubMed ID: 27224474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPD.
    Scherr A; Graf R; Bain M; Christ-Crain M; Müller B; Tamm M; Stolz D
    Chest; 2013 Feb; 143(2):379-387. PubMed ID: 22922487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.
    Bozinovski S; Hutchinson A; Thompson M; Macgregor L; Black J; Giannakis E; Karlsson AS; Silvestrini R; Smallwood D; Vlahos R; Irving LB; Anderson GP
    Am J Respir Crit Care Med; 2008 Feb; 177(3):269-78. PubMed ID: 18006888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
    Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.
    Soler N; Esperatti M; Ewig S; Huerta A; Agustí C; Torres A
    Eur Respir J; 2012 Dec; 40(6):1344-53. PubMed ID: 22523352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
    Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
    Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.
    Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T
    COPD; 2016; 13(2):139-45. PubMed ID: 26514682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Inflammatory Marker CRP Was Better Predictor of Readmission for AECOPD Than Sputum Inflammatory Markers.
    Jing Z; Chun C; Ning S; Hong Z; Bei H; Wan-Zhen Y
    Arch Bronconeumol; 2016 Mar; 52(3):138-44. PubMed ID: 26002550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.